Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,330 | -5,450 | -2,900 | -7,320 | -4,750 |
| Depreciation Amortization | 170 | 100 | 70 | 340 | 170 |
| Other Working Capital | 850 | 990 | 530 | 320 | 250 |
| Other Operating Activity | 1,210 | 810 | 390 | 810 | 640 |
| Operating Cash Flow | $-5,100 | $-3,550 | $-1,910 | $-5,850 | $-3,690 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -160 | -160 | -110 | -150 | -100 |
| Other Investing Activity | 40 | 1,100 | 1,010 | -1,900 | -250 |
| Investing Cash Flow | $-120 | $940 | $900 | $-2,050 | $-350 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 3 | -310 | -460 | 10,960 | 9,440 |
| Financing Cash Flow | $3 | $-310 | $-460 | $10,960 | $9,440 |
| Beginning Cash Position | 12,020 | 12,020 | 12,020 | 8,960 | 8,960 |
| End Cash Position | 6,790 | 9,090 | 10,550 | 12,020 | 14,340 |
| Net Cash Flow | $-5,230 | $-2,920 | $-1,470 | $3,050 | $5,370 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,100 | -3,550 | -1,910 | -5,850 | -3,690 |
| Free Cash Flow | -5,100 | -3,550 | -1,910 | -5,850 | -3,690 |